BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37827431)

  • 21. [Reversible blindness caused by an invasive prolactinoma].
    Schöfl-Siegert B; Brabant G; von zur Mühlen A; Schöfl C
    Dtsch Med Wochenschr; 2001 May; 126(21):621-4. PubMed ID: 11413749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of psychosis associated with a prolactinoma: case report and review of the literature.
    Ali S; Miller KK; Freudenreich O
    Psychosomatics; 2010; 51(5):370-6. PubMed ID: 20833935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucocele-like formation leading to neurological symptoms in prolactin-secreting pituitary adenomas under dopamine agonist therapy.
    Abe T; Lüdecke DK
    Surg Neurol; 1999 Sep; 52(3):274-9. PubMed ID: 10511086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else.
    Cho A; Vila G; Marik W; Klotz S; Wolfsberger S; Micko A
    Front Endocrinol (Lausanne); 2022; 13():901385. PubMed ID: 36147567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Macroprolactinoma revealed by an exophthalmos].
    Harzallah F; Harzallah L; Ben Brahim A; Mekaouer A; Slimane H
    J Fr Ophtalmol; 2009 Feb; 32(2):133.e1-3. PubMed ID: 20579476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperprolactinaemia associated with a complex cystic pituitary mass: medical versus surgical therapy.
    Inder WJ; Macfarlane MR
    Intern Med J; 2004; 34(9-10):573-6. PubMed ID: 15482272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of age on the clinical presentation of prolactinomas in male patients.
    Delgrange E; Maiter D; Donckier J; Tourniaire J
    Gerontology; 1999; 45(3):160-4. PubMed ID: 10202261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hook effect in prolactin immunoassays.
    Al Sifri SN; Raef H
    Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox.
    Tamagno G; Daly AF; Deprez M; Vroonen L; Andris C; Martin D; Beckers A
    Ann Endocrinol (Paris); 2008 Feb; 69(1):47-52. PubMed ID: 18082643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
    Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
    J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactinoma surgery.
    Jan M; Dufour H; Brue T; Jaquet P
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):118-9. PubMed ID: 17512893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactinoma-associated headache and dopamine agonist treatment.
    Kallestrup MM; Kasch H; Østerby T; Nielsen E; Jensen TS; Jørgensen JO
    Cephalalgia; 2014 Jun; 34(7):493-502. PubMed ID: 24351278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men.
    Shimon I; Benbassat C; Hadani M
    Eur J Endocrinol; 2007 Feb; 156(2):225-31. PubMed ID: 17287412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Macroadenoma of the pituitary gland with moderate hyperprolactinaemia].
    Harms E; Siggelkow H; Buchfelder M; Saeger W; Hüfner M
    Dtsch Med Wochenschr; 2003 Mar; 128(13):667-70. PubMed ID: 12660899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation.
    Levine SN; Ishaq S; Nanda A; Wilson JD; Gonzalez-Toledo E
    Ann Diagn Pathol; 2013 Aug; 17(4):361-6. PubMed ID: 23602507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary apoplexy due to prolactinoma in a Taiwanese boy: patient report and review of the literature.
    Yang MH; Chuang H; Jung SM; Van YH; Lo FS
    J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1301-5. PubMed ID: 14714755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter?
    Li M; Keiser HD; Peeva E
    Clin Rheumatol; 2006 Jul; 25(4):602-5. PubMed ID: 16404500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma.
    Dombrowski RC; Romeo JH; Aron DC
    Ann Pharmacother; 1995 Oct; 29(10):999-1001. PubMed ID: 8845563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misdiagnosis due to the hook effect in prolactin assay.
    Yener S; Comlekci A; Arda N; Men S; Yesil S
    Med Princ Pract; 2008; 17(5):429-31. PubMed ID: 18685288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.